S-1-based vs non-S-1-based chemotherapy in advanced gastric cancer: A meta-analysis

doi:10.3748/wjg.v20.i33.11886

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 33

This Article

(302)

(340)

(0)

(6660)

(25)

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Meta-Analysis

World J Gastroenterol. Sep 7, 2014; 20(33): 11886-11893
Published online Sep 7, 2014. doi: 10.3748/wjg.v20.i33.11886

Full Size Figure Download Figure

Figure 2 Comparison of progression-free survival between S-1-based chemotherapy and non-S-1-based chemotherapy. Values less than 1 indicate a survival advantage for S-1 based chemotherapy. PFS: Progression-free survival; HR: Hazard ratio.

Citation: Yang J, Zhou Y, Min K, Yao Q, Xu CN. S-1-based vs non-S-1-based chemotherapy in advanced gastric cancer: A meta-analysis. World J Gastroenterol 2014; 20(33): 11886-11893
URL: https://www.wjgnet.com/1007-9327/full/v20/i33/11886.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i33.11886

Yang J, Zhou Y, Min K, Yao Q, Xu CN. S-1-based vs non-S-1-based chemotherapy in advanced gastric cancer: A meta-analysis. World J Gastroenterol 2014; 20(33): 11886-11893 [PMID: 25206296 DOI: 10.3748/wjg.v20.i33.11886]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.